| Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients A Giordano, M Giuliano, M De Laurentiis, A Eleuteri, F Iorio, R Tagliaferri, ... Breast cancer research and treatment 129, 451-458, 2011 | 41 | 2011 |
| The role of human resource information system on operational efficiency: evidence from MNCs operating in Bangladesh S Hosain, AHM Manzurul Arefin, MA Hossin Asian Journal of Economics, Business and Accounting 18 (2), 29-47, 2020 | 28 | 2020 |
| Effects of e-recruitment and e-training on human resource performance: a case study of telkom kenya J Mwangi, JM Reuben Effects of E-Recruitment and E-Training on Human Resource Performance: A …, 2019 | 12* | 2019 |
| Cytoplasmic IgM in leukemic B cells by flow cytometry KC Loftin, JM Reuben, EM Hersh, D Sujansky Leukemia research 9 (11), 1379-1387, 1985 | 10 | 1985 |
| Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patients EN Cohen, G Jayachandran, H Gao, W Qiao, S Liu, J He, Y Qiao, L Yao, ... Translational Lung Cancer Research 9 (5), 1974, 2020 | 9 | 2020 |
| Abstract CT057: a single-arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are … LJ Goldstein, RP Perez, DA Yardley, LK Han, JM Reuben, S McCanna, ... Cancer Research 76 (14_Supplement), CT057-CT057, 2016 | 9 | 2016 |
| Modeling the prognostic impact of circulating tumor cells enumeration in metastatic breast cancer for clinical trial design simulation L Gerratana, JY Pierga, JM Reuben, AA Davis, FH Wehbe, L Dirix, ... The oncologist 27 (7), e561-e570, 2022 | 8 | 2022 |
| Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling LR Wu, P Dai, MX Wang, SX Chen, EN Cohen, G Jayachandran, ... Nature communications 13 (1), 1791, 2022 | 8 | 2022 |
| Internet of Things (IoT) and quality of higher education in Kenya N Letting, J Mwikya International Journal of Management and Leadership Studies 2 (1), 14-16, 2020 | 8 | 2020 |
| Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key. B Lim, WA Woodward, X Wang, JM Reuben, NT Ueno Nature reviews. Cancer 18 (8), 526-526, 2018 | 8 | 2018 |
| Self-reported sleep disturbance in patients with advanced cancer: Frequency, intensity, and factors associated with response to outpatient supportive care consultation-A … S Yennurajalingam, G Chisholm, SL Palla, H Holmes, JM Reuben, ... PALLIATIVE AND SUPPORTIVE CARE 12 (4), 1-9, 2014 | 8 | 2014 |
| The combination of rituximab and GM-CSF in elderly patients with chronic lymphocytic leukemia (CLL) A Ferrajoli, S O’Brien, S Faderl, WG Wierda, E Schlette, JL Jorgensen, ... Journal of Clinical Oncology 24 (18_suppl), 6602-6602, 2006 | 8 | 2006 |
| Rituximab in combination with GM-CSF (leukine) for patients with recurrent indolent lymphoma. P McLaughlin, MA Rodriguez, J Reuben, K East, E Grimm, ... Blood 98 (11), 605A-605A, 2001 | 8 | 2001 |
| A phase I study of intravenous azimexon therapy in human cancer YZ Patt, EM Hersh, J Reuben, L Claghorn, G Mavligit Journal of Immunotherapy 5 (4), 313-318, 1986 | 8 | 1986 |
| In vitro modulation of purine enzyme metabolism and lymphocyte surface marker expression by thymosin fraction 5 in homosexual males JL Murray, JM Reuben, CG Munn, G Newell, PWA Mansell, EM Hersh International journal of immunopharmacology 7 (5), 661-669, 1985 | 8 | 1985 |
| Lymphadenopathy among homosexual men LA Guarda, JJ Butler, P Mansell, EM Hersh, J Reuben, GR Newell LABORATORY INVESTIGATION 48 (1), A31-A31, 1983 | 8 | 1983 |
| Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer T Yamauchi, JRE Fernandez, CK Imamura, H Yamauchi, H Jinno, ... Oncotarget 9 (6), 6872, 2018 | 7 | 2018 |
| Epithelial-mesenchymal transition in patients with HER2+ metastatic breast cancer. A Giordano, M Mego, B Lee, S Anfossi, CA Parker, RH Alvarez, NT Ueno, ... Journal of Clinical Oncology 29 (15_suppl), 623-623, 2011 | 7 | 2011 |
| Initial clinical studies with copovithane GN Hortobagyi, EM Hersh, NEJ Papadopoulos, D Frye, A Rios, ... Journal of Immunotherapy 5 (4), 319-329, 1986 | 7 | 1986 |
| Abstract P3-09-12: Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory … H Gao, K Kida, EN Cohen, A Alexander, B Lim, C Parker, S Tin, V Valero, ... Cancer Research 80 (4_Supplement), P3-09-12-P3-09-12, 2020 | 6 | 2020 |
Dr. Johnmark OburaSENIOR LECTURER IN SCHOOL OF BUSINESS, BOMET UNIVERSITY COLLEGE, KENYAVerified email at buc.ac.ke
